Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 310 | 17755 | 29.1 | 77% |
Classes in level above (level 3) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 464 | 22271 | CARCINOMA RENAL CELL//ANGIOMYOLIPOMA//TUBEROUS SCLEROSIS |
Classes in level below (level 1) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CARCINOMA RENAL CELL | Author keyword | 2211 | 47% | 19% | 3440 |
| 2 | PARTIAL NEPHRECTOMY | Author keyword | 677 | 73% | 3% | 512 |
| 3 | NEPHRECTOMY | Author keyword | 676 | 48% | 6% | 1042 |
| 4 | NEPHRON SPARING SURGERY | Author keyword | 532 | 84% | 2% | 293 |
| 5 | HEMANGIOBLASTOMAS | Author keyword | 525 | 77% | 2% | 354 |
| 6 | KIDNEY NEOPLASMS | Author keyword | 431 | 55% | 3% | 541 |
| 7 | VON HIPPEL LINDAU DISEASE | Author keyword | 417 | 74% | 2% | 313 |
| 8 | RENAL CELL | Author keyword | 400 | 67% | 2% | 365 |
| 9 | SUNITINIB | Author keyword | 397 | 48% | 3% | 613 |
| 10 | KIDNEY CANCER | Author keyword | 265 | 51% | 2% | 374 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | CARCINOMA RENAL CELL | 2211 | 47% | 19% | 3440 | Search CARCINOMA++RENAL+CELL | Search CARCINOMA++RENAL+CELL |
| 2 | PARTIAL NEPHRECTOMY | 677 | 73% | 3% | 512 | Search PARTIAL+NEPHRECTOMY | Search PARTIAL+NEPHRECTOMY |
| 3 | NEPHRECTOMY | 676 | 48% | 6% | 1042 | Search NEPHRECTOMY | Search NEPHRECTOMY |
| 4 | NEPHRON SPARING SURGERY | 532 | 84% | 2% | 293 | Search NEPHRON+SPARING+SURGERY | Search NEPHRON+SPARING+SURGERY |
| 5 | HEMANGIOBLASTOMAS | 525 | 77% | 2% | 354 | Search HEMANGIOBLASTOMAS | Search HEMANGIOBLASTOMAS |
| 6 | KIDNEY NEOPLASMS | 431 | 55% | 3% | 541 | Search KIDNEY+NEOPLASMS | Search KIDNEY+NEOPLASMS |
| 7 | VON HIPPEL LINDAU DISEASE | 417 | 74% | 2% | 313 | Search VON+HIPPEL+LINDAU+DISEASE | Search VON+HIPPEL+LINDAU+DISEASE |
| 8 | RENAL CELL | 400 | 67% | 2% | 365 | Search RENAL+CELL | Search RENAL+CELL |
| 9 | SUNITINIB | 397 | 48% | 3% | 613 | Search SUNITINIB | Search SUNITINIB |
| 10 | KIDNEY CANCER | 265 | 51% | 2% | 374 | Search KIDNEY+CANCER | Search KIDNEY+CANCER |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | NEPHRON SPARING SURGERY | 2196 | 84% | 7% | 1183 |
| 2 | RADICAL NEPHRECTOMY | 1979 | 79% | 7% | 1268 |
| 3 | LAPAROSCOPIC PARTIAL NEPHRECTOMY | 780 | 76% | 3% | 548 |
| 4 | CELL CARCINOMA | 552 | 24% | 11% | 1981 |
| 5 | CARCINOMA RENAL CELL | 532 | 23% | 11% | 1993 |
| 6 | PARTIAL NEPHRECTOMY | 531 | 62% | 3% | 546 |
| 7 | SUNITINIB | 527 | 54% | 4% | 685 |
| 8 | KIDNEY CANCER | 330 | 54% | 2% | 419 |
| 9 | COLLECTING DUCT CARCINOMA | 303 | 87% | 1% | 146 |
| 10 | CYTOREDUCTIVE NEPHRECTOMY | 245 | 86% | 1% | 124 |
Journals |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | JOURNAL OF ENDOUROLOGY | 79 | 13% | 3% | 576 |
| 2 | CLINICAL GENITOURINARY CANCER | 48 | 28% | 1% | 146 |
| 3 | UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 16 | 10% | 1% | 150 |
| 4 | CURRENT OPINION IN UROLOGY | 12 | 11% | 1% | 105 |
| 5 | EUROPEAN UROLOGY SUPPLEMENTS | 8 | 12% | 0% | 65 |
| 6 | ARCHIVOS ESPANOLES DE UROLOGIA | 4 | 10% | 0% | 39 |
| 7 | TARGETED ONCOLOGY | 3 | 10% | 0% | 31 |
| 8 | MINERVA UROLOGICA E NEFROLOGICA | 2 | 11% | 0% | 19 |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| A Systematic Review of Sequencing and Combinations of Systemic Therapy in Metastatic Renal Cancer | 2015 | 9 | 42 | 98% |
| Understanding Pathologic Variants of Renal Cell Carcinoma: Distilling Therapeutic Opportunities from Biologic Complexity | 2015 | 6 | 102 | 88% |
| Renal cell carcinoma | 2009 | 311 | 123 | 87% |
| The Epidemiology of Renal Cell Carcinoma | 2011 | 160 | 43 | 74% |
| Renal-cell carcinoma | 1996 | 934 | 137 | 69% |
| Preoperatively Misclassified, Surgically Removed Benign Renal Masses: A Systematic Review of Surgical Series and United States Population Level Burden Estimate | 2015 | 3 | 28 | 93% |
| Decline in Renal Function after Partial Nephrectomy: Etiology and Prevention | 2015 | 3 | 47 | 91% |
| Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: An up-to-date review and meta-analysis of clinical trials | 2015 | 5 | 54 | 56% |
| International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality | 2015 | 4 | 31 | 68% |
| Renal-cell carcinoma | 2005 | 621 | 95 | 60% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SECT L AROSCOP ROBOT SURG | 39 | 48% | 0.3% | 59 |
| 2 | UROL ONCOL | 37 | 20% | 0.9% | 164 |
| 3 | UROL ONCOL BRANCH | 33 | 22% | 0.8% | 136 |
| 4 | SOLID TUMOR ONCOL UROL | 30 | 79% | 0.1% | 19 |
| 5 | GLICKMAN UROL | 23 | 19% | 0.6% | 111 |
| 6 | CLIN MINIMALLY INVAS UROL CANC TREATMENT | 23 | 72% | 0.1% | 18 |
| 7 | GLICKMAN UROL KIDNEY | 21 | 14% | 0.8% | 144 |
| 8 | KIDNEY CANC | 21 | 78% | 0.1% | 14 |
| 9 | KIDNEY CANC PROGRAM | 18 | 67% | 0.1% | 16 |
| 10 | SECT L AROSCOP MINIMALLY INVAS SURG | 18 | 34% | 0.2% | 42 |
Related classes at same level (level 2) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000013583 | ANGIOMYOLIPOMA//TUBEROUS SCLEROSIS//TUBEROUS SCLEROSIS COMPLEX |
| 2 | 0.0000009450 | HIF 1 ALPHA//HYPOXIA INDUCIBLE FACTOR//HIF 1 |
| 3 | 0.0000008608 | WILMS TUMOR//WT1//RHABDOID TUMOR |
| 4 | 0.0000006666 | GLASGOW PROGNOSTIC SCORE//NEUTROPHIL TO LYMPHOCYTE RATIO//NEUTROPHIL LYMPHOCYTE RATIO |
| 5 | 0.0000006136 | RENAL TRAUMA//RENAL ARTERIOVENOUS FISTULA//PERCUTANEOUS RENAL BIOPSY |
| 6 | 0.0000005891 | DCE MRI//CT PERFUSION//INTRAVOXEL INCOHERENT MOTION |
| 7 | 0.0000005712 | INTERLEUKIN 2//GRANZYME B//PERFORIN |
| 8 | 0.0000005646 | HAND FOOT SYNDROME//RADIATION RECALL//EXTRAVASATION |
| 9 | 0.0000005542 | NOTES//SINGLE INCISION LAPAROSCOPIC SURGERY//LAPAROENDOSCOPIC SINGLE SITE SURGERY |
| 10 | 0.0000005510 | IQGAP1//LRIG1//MIG 6 |